ArticleMolecular pharmaceutics2013

Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation.

David W Woessner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.